Iniciar sesión Regístrese gratis

Ayala Pharmaceuticals P/E Adelante

¿Qué es el P/E Adelante de Ayala Pharmaceuticals?

El P/E Adelante de Ayala Pharmaceuticals Inc. es -0.14

¿Cuál es la definición de P/E Adelante?



La relación precio a futuro es la relación entre el precio de las acciones de una empresa y las ganancias por acción estimadas de la compañía para los próximos doce meses.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

P/E Adelante de compañías en Sector Health Care en NASDAQ en comparadas con Ayala Pharmaceuticals

¿Qué hace Ayala Pharmaceuticals?

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

Empresas con p/e adelante similar a Ayala Pharmaceuticals